EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.8.29 | gene PTDSS1 | Homo sapiens |
2.7.8.29 | gene PTDSS1, expression analysis | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.7.8.29 | L265P | naturally gain-of-function mutation mutation of PSS1 | Homo sapiens |
2.7.8.29 | P269L | naturally gain-of-function mutation mutation of PSS1 | Homo sapiens |
2.7.8.29 | P269S | naturally gain-of-function mutation mutation of PSS1 | Homo sapiens |
2.7.8.29 | Q353R | naturally gain-of-function mutation mutation of PSS1, which resides in a separate cytosolic domain and has only s slight effect on enzyme activity | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.8.29 | (3-sn-phosphatidyl)-L-serine | end-product inhibition of isozyme PSS1; strong end-product inhibition of isozyme PSS1 | Homo sapiens | |
2.7.8.29 | additional information | addition of phosphatidylcholine instead of phosphatidylserine does not reduce the rate of phosphatidylserine synthesis | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.7.8.29 | endoplasmic reticulum | - |
Homo sapiens | 5783 | - |
2.7.8.29 | membrane | integral membrane protein, membrane topology overview | Homo sapiens | 16020 | - |
2.7.8.29 | mitochondrial membrane | - |
Homo sapiens | 31966 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.8.29 | L-1-phosphatidylcholine + L-serine | Homo sapiens | isozyme PSS1 | L-1-phosphatidylserine + choline | - |
r | |
2.7.8.29 | L-1-phosphatidylethanolamine + L-serine | Homo sapiens | isozyme PSS2 | L-1-phosphatidylserine + ethanolamine | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.8.29 | Homo sapiens | P48651 | - |
- |
2.7.8.29 | Homo sapiens | Q9BVG9 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.8.29 | fibroblast | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.8.29 | L-1-phosphatidylcholine + L-serine | isozyme PSS1 | Homo sapiens | L-1-phosphatidylserine + choline | - |
r | |
2.7.8.29 | L-1-phosphatidylethanolamine + L-serine | isozyme PSS2 | Homo sapiens | L-1-phosphatidylserine + ethanolamine | - |
r |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.8.29 | phosphatidylserine synthase 1 | - |
Homo sapiens |
2.7.8.29 | phosphatidylserine synthase 2 | - |
Homo sapiens |
2.7.8.29 | PSS1 | - |
Homo sapiens |
2.7.8.29 | PSS2 | - |
Homo sapiens |
2.7.8.29 | PTDSS1 | - |
Homo sapiens |
2.7.8.29 | PTDSS2 | - |
Homo sapiens |
2.7.8.29 | serine-phosphatidylcholine phosphatidyltransferase | - |
Homo sapiens |
2.7.8.29 | serine-phosphatidylethanolamine phosphatidyltransferase | - |
Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.8.29 | malfunction | gain-of-function mutation of PTDSS1 encoding phosphatidylserine synthase 1, a causative heterozygous missense mutations in gene PTDSS1, causes Lenz-Majewski syndrome (LMS), a syndrome of intellectual disability and multiple congenital anomalies that features generalized craniotubular hyperostosis. End-product inhibition of PSS1 by phosphatidylserine is markedly reduced in the mutant. The gain-of-function mutation is associated with regulatory dysfunction of PSS1. Phenotypes, overview | Homo sapiens |
2.7.8.29 | metabolism | link between phosphatidylserine synthesis and bone metabolism | Homo sapiens |
2.7.8.29 | physiological function | isozyme PSS1 is one of two enzymes involved in the production of phosphatidylserine | Homo sapiens |